StockData
Vistagen Therapeutics, Inc. logo

Vistagen Therapeutics, Inc. (VTGN) stock

VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3078% below fair value
$0.20+0.01 (+6.12%)

Close on Nov 18, 2026Market cap $8.85MP/E –Yield –

Vistagen Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Vistagen Therapeutics's price to sales ratio was 3.1× on Nov 11, 2026, against 98.3× a year earlier. Over the last 5 years it ranged from 2.7× to 331.1×, with a median of 78.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.1×−99.6
2025Apr 30, 2025102.6×+0.5
2024Dec 31, 2024102.1×+52.3
2023Dec 29, 202349.8×+25.1
2022Oct 31, 202224.7×−178.0
2021Dec 31, 2021202.7×−100.3
2020Dec 31, 2020303.0×+290.7
2017Jul 31, 201712.4×−51.1
2013Jul 31, 201363.4×+45.4
2012Dec 31, 201218.1×−7.6
2011Dec 30, 201125.7×–

More Vistagen Therapeutics figures

See a number that looks wrong?